These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8832193)

  • 1. Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis.
    Carpay HA; Arts WF; Vermeulen J; Stroink H; Brouwer OF; Peters AC; van Donselaar CA; Aldenkamp AP
    Epilepsy Res; 1996 Jul; 24(3):173-81. PubMed ID: 8832193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Personal Impact of Epilepsy Scale (PIES).
    Fisher RS; Nune G; Roberts SE; Cramer JA
    Epilepsy Behav; 2015 Jan; 42():140-6. PubMed ID: 25450530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing the Pediatric Refractory Epilepsy Questionnaire: a pilot study.
    Purusothaman V; Ryther RC; Bertrand M; Harker LA; Jeffe DB; Wallendorf M; Smyth MD; Limbrick DD
    Epilepsy Behav; 2014 Aug; 37():26-31. PubMed ID: 24967697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
    Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
    Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48.
    Cramer JA; Westbrook LE; Devinsky O; Perrine K; Glassman MB; Camfield C
    Epilepsia; 1999 Aug; 40(8):1114-21. PubMed ID: 10448825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the Pediatric Epilepsy Side Effects Questionnaire.
    Morita DA; Glauser TA; Modi AC
    Neurology; 2012 Sep; 79(12):1252-8. PubMed ID: 22875082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life.
    Wagner AK; Keller SD; Kosinski M; Baker GA; Jacoby A; Hsu MA; Chadwick DW; Ware JE
    Qual Life Res; 1995 Apr; 4(2):115-34. PubMed ID: 7780379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring stigma in children with epilepsy and their parents: instrument development and testing.
    Austin JK; MacLeod J; Dunn DW; Shen J; Perkins SM
    Epilepsy Behav; 2004 Aug; 5(4):472-82. PubMed ID: 15256183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale.
    O'Donoghue MF; Duncan JS; Sander JW
    Epilepsia; 1996 Jun; 37(6):563-71. PubMed ID: 8641234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure severity in children with epilepsy: a parent-completed scale compared with clinical data.
    Carpay JA; Vermuelen J; Stroink H; Brouwer OF; Peters AC; Aldenkamp AP; van Donselaar CA; Arts WF
    Epilepsia; 1997 Mar; 38(3):346-52. PubMed ID: 9070598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome assessment in epilepsy: available rating scales for adults and methodological issues pertaining to the development of scales for childhood epilepsy.
    Carpay HA; Arts WF
    Epilepsy Res; 1996 Jul; 24(3):127-36. PubMed ID: 8832189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a new quality of life measure for children with epilepsy.
    Sabaz M; Cairns DR; Lawson JA; Nheu N; Bleasel AF; Bye AM
    Epilepsia; 2000 Jun; 41(6):765-74. PubMed ID: 10840411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India.
    Pal DK; Das T; Chaudhury G; Johnson AL; Neville BG
    Lancet; 1998 Jan; 351(9095):19-23. PubMed ID: 9433424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liverpool Seizure Severity Scale revisited.
    Baker GA; Smith DF; Jacoby A; Hayes JA; Chadwick DW
    Seizure; 1998 Jun; 7(3):201-5. PubMed ID: 9700832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determinants of seizure severity in Nigerian epileptics.
    Imam I; Talabi OA; Sanya EO; Ogunniyi A
    Niger J Clin Pract; 2005 Dec; 8(2):94-6. PubMed ID: 16477861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a seizure severity scale as an outcome measure in epilepsy.
    Baker GA; Smith DF; Dewey M; Morrow J; Crawford PM; Chadwick DW
    Epilepsy Res; 1991 Apr; 8(3):245-51. PubMed ID: 1868824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and psychometric evaluation of the youth and parent versions of the Epilepsy Disclosure Scale (EDS).
    Benson A; Lambert V; Gallagher P; O'Toole S; Shahwan A; Austin JK
    Epilepsy Behav; 2018 May; 82():111-118. PubMed ID: 29604483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disability due to restrictions in childhood epilepsy.
    Carpay HA; Vermeulen J; Stroink H; Brouwer OF; Peters AC; van Donselaar CA; Aldenkamp AP; Arts WF
    Dev Med Child Neurol; 1997 Aug; 39(8):521-6. PubMed ID: 9295847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.